Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 11, 2018

SELL
$115.92 - $148.54 $284,699 - $364,814
-2,456 Closed
0 $0
Q4 2017

Jan 19, 2018

BUY
$114.49 - $139.98 $14,425 - $17,637
126 Added 5.41%
2,456 $311,000
Q3 2017

Oct 12, 2017

BUY
$72.53 - $118.27 $168,994 - $275,569
2,330
2,330 $277,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $34.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track V Wealth Advisors LLC Portfolio

Follow V Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of V Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on V Wealth Advisors LLC with notifications on news.